The pre-incubation of CLL B cells with Bafetinib and Ibrutinib reduced cell viability (Figure S4A); the latter data were confirmed by western blotting analyses of PARP, Lyn and ERK (Figure S4B). The gene discussed is LYN; the disease is B-cell chronic lymphocytic leukemia.